As shown in topic 4.5.2, IGF-1 is also a hepatokine, in which a lack of it can imply a risk for the development of sarcopenia by the mechanism of muscle hypertrophy and atrophy inhibition. The gene discussed is IGF1; the disease is sarcopenia.